A new study suggests that the diabetes meds Actos and Avandia may double patients' risk of heart failure. The study, published in Diabetes Care, included data from more than 78,000 patients. Researchers say the medications not only doubled the risk of heart failure, but the risk was the same for patients taking a low dose of the medication as those who took a higher dose.
A Food and Drug Administration (FDA) advisory committee voted Monday to keep the diabetes med Avandia on the market despite links to heart problems. But the panel did recommend that drugmaker GlaxoSmithKline strengthen Avandia's warning label to warn against the med's use by people with heart problems such as congestive heart failure.
Source: HealthDay News, Medical News Today
Monday, August 6, 2007
Thursday, August 2, 2007
In-Depth: How do clinical trials work?
Clinical trials are a vital part of the testing of new medications and treatments. You may have seen announcements for these studies and wondered what it would be like to participate in the testing of these new treatments.
In this article in the Manchester Evening News, Dr. John Robinson explains what participants in clinical trials can expect. He also talks about the purpose behind these studies and how they fit into the process of getting new medications and treatments approved for general use.
In this article in the Manchester Evening News, Dr. John Robinson explains what participants in clinical trials can expect. He also talks about the purpose behind these studies and how they fit into the process of getting new medications and treatments approved for general use.
